These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36064943)

  • 61. Making a Genetic Diagnosis in a Level IV Neonatal Intensive Care Unit Population: Who, When, How, and at What Cost?
    Swaggart KA; Swarr DT; Tolusso LK; He H; Dawson DB; Suhrie KR
    J Pediatr; 2019 Oct; 213():211-217.e4. PubMed ID: 31255390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical impact of genomic testing in patients with suspected monogenic kidney disease.
    Jayasinghe K; Stark Z; Kerr PG; Gaff C; Martyn M; Whitlam J; Creighton B; Donaldson E; Hunter M; Jarmolowicz A; Johnstone L; Krzesinski E; Lunke S; Lynch E; Nicholls K; Patel C; Prawer Y; Ryan J; See EJ; Talbot A; Trainer A; Tytherleigh R; Valente G; Wallis M; Wardrop L; West KH; White SM; Wilkins E; Mallett AJ; Quinlan C
    Genet Med; 2021 Jan; 23(1):183-191. PubMed ID: 32939031
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases.
    Bick D; Jones M; Taylor SL; Taft RJ; Belmont J
    J Med Genet; 2019 Dec; 56(12):783-791. PubMed ID: 31023718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Implementing genomics in the neonatal period: An assessment of parental decision making and anxiety.
    Wainstein T; Campbell T; Stojkova BJ; Lavoie PM; Elliott AM
    J Genet Couns; 2022 Dec; 31(6):1306-1316. PubMed ID: 35733279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolving fetal phenotypes and clinical impact of progressive prenatal exome sequencing pathways: cohort study.
    Mone F; Abu Subieh H; Doyle S; Hamilton S; Mcmullan DJ; Allen S; Marton T; Williams D; Kilby MD
    Ultrasound Obstet Gynecol; 2022 Jun; 59(6):723-730. PubMed ID: 34940998
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants.
    Petrikin JE; Cakici JA; Clark MM; Willig LK; Sweeney NM; Farrow EG; Saunders CJ; Thiffault I; Miller NA; Zellmer L; Herd SM; Holmes AM; Batalov S; Veeraraghavan N; Smith LD; Dimmock DP; Leeder JS; Kingsmore SF
    NPJ Genom Med; 2018; 3():6. PubMed ID: 29449963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
    Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL
    Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants.
    McCall EM; Alderdice F; Halliday HL; Vohra S; Johnston L
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004210. PubMed ID: 29431872
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of whole exome sequencing in the NICU: Case of an extremely low birth weight infant with syndromic features.
    Kuehne B; Heine E; Dafsari HS; Irwin R; Heller R; Bangen U; Brockmeier K; Kribs A; Oberthuer A; Cirak S
    Mol Cell Probes; 2019 Jun; 45():89-93. PubMed ID: 30885829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early diagnosis of Pearson syndrome in neonatal intensive care following rapid mitochondrial genome sequencing in tandem with exome sequencing.
    Akesson LS; Eggers S; Love CJ; Chong B; Krzesinski EI; Brown NJ; Tan TY; Richmond CM; Thorburn DR; Christodoulou J; Hunter MF; Lunke S; Stark Z
    Eur J Hum Genet; 2019 Dec; 27(12):1821-1826. PubMed ID: 31358953
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis.
    Xiao F; Yan K; Tang M; Ji X; Hu L; Yang L; Zhou W
    Expert Rev Mol Diagn; 2022 Aug; 22(8):833-840. PubMed ID: 36082848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid Whole Genome Sequencing in Critically Ill Neonates Enables Precision Medicine Pipeline.
    Beaman M; Fisher K; McDonald M; Tan QKG; Jackson D; Cocanougher BT; Landstrom AP; Hobbs CA; Cotten M; Cohen JL
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey.
    Guner Yilmaz B; Akgun-Dogan O; Ozdemir O; Yuksel B; Hatirnaz Ng O; Bilguvar K; Ay B; Ozkose GS; Aydin E; Yigit A; Bulut A; Esen FN; Beken S; Aktas S; Demirel A; Arcagok BC; Kazanci E; Bingol İ; Umur O; Sik G; Isik U; Ersoy M; Korkmaz A; Citak A; Mardinoglu A; Ozbek U; Alanay Y
    Front Pediatr; 2024; 12():1412880. PubMed ID: 39026936
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications.
    Schobers G; Schieving JH; Yntema HG; Pennings M; Pfundt R; Derks R; Hofste T; de Wijs I; Wieskamp N; van den Heuvel S; Galbany JC; Gilissen C; Nelen M; Brunner HG; Kleefstra T; Kamsteeg EJ; Willemsen MAAP; Vissers LELM
    Genome Med; 2022 Jun; 14(1):66. PubMed ID: 35710456
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience.
    Miller CR; Lee K; Pfau RB; Reshmi SC; Corsmeier DJ; Hashimoto S; Dave-Wala A; Jayaraman V; Koboldt D; Matthews T; Mouhlas D; Stein M; McKinney A; Grossman T; Kelly BJ; White P; Magrini V; Wilson RK; Mardis ER; Cottrell CE
    Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32371413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exome and Whole Genome Sequencing in the Neonatal Intensive Care Unit.
    Muriello M
    Clin Perinatol; 2022 Mar; 49(1):167-179. PubMed ID: 35209999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
    Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
    Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.
    Mone F; Eberhardt RY; Hurles ME; Mcmullan DJ; Maher ER; Lord J; Chitty LS; Dempsey E; Homfray T; Giordano JL; Wapner RJ; Sun L; Sparks TN; Norton ME; Kilby MD
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):509-518. PubMed ID: 33847422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genome-wide sequencing in acutely ill infants: genomic medicine's critical application?
    Friedman JM; Bombard Y; Cornel MC; Fernandez CV; Junker AK; Plon SE; Stark Z; Knoppers BM;
    Genet Med; 2019 Feb; 21(2):498-504. PubMed ID: 29895853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results.
    Baldridge D; Heeley J; Vineyard M; Manwaring L; Toler TL; Fassi E; Fiala E; Brown S; Goss CW; Willing M; Grange DK; Kozel BA; Shinawi M
    Genet Med; 2017 Sep; 19(9):1040-1048. PubMed ID: 28252636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.